Last updated on April 2019

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

Brief description of study

The rationale for the current protocol is to collect data from extended follow up in subjects that have received a kidney transplant following imlifidase dosing to provide a better understanding regarding the long-term outcome for these subjects. Data of parameters such as patient and graft survival, comorbidity, treatment of rebound of DSAs and quality of life as well as anti-drug antibody levels will be collected.

This prospective, observational follow up study of subjects who have received imlifidase prior to kidney transplantation will provide important data to future prescribers and patients of the potential long-term benefits of imlifidase mediated transplantation.

Clinical Study Identifier: NCT03611621

Find a site near you

Start Over